One careful re-analysis. Yours to keep.
Drop in the genetic file you already have. We detect whether it is a genotyping-chip export, whole-genome data, or aligned reads, then show you what your report will cover before you pay. We re-read it and attribute every finding to its source, so a result is something you can check, not just a number. Every report stays yours for good.
Choose your starting point
Not sure which file you have? Drop it in and we will tell you. Otherwise, pick below.
Chip report
For 23andMe, AncestryDNA, MyHeritage, FamilyTreeDNA, LivingDNA and similar array raw-data exports. Everything your chip can call, fully attributed. Carrier status and the full clinical-findings panel need whole-genome data (WGS).
- Clinical findings your array covers
- Pharmacogenomics for the genes your chip typed
- Traits, ancestry and the Frontier module
- Polygenic scores and single-gene findings
- Plain-language explainers, save as PDF
Already on a chip report? Upgrade to the full WGS report for €40 any time.
Full report (WGS)
Every module over your whole-genome file. Upload a gVCF for coverage-proven findings (a plain VCF also works). A one-time analysis, yours to keep.
- Clinical findings (ClinVar and ACMG SF)
- Carrier status and pharmacogenomics
- Traits, ancestry, Frontier and the Fringe
- Real polygenic risk scores
- Pinned, attributed, reproducible sources
The bundle
Deep Read works out to €110 here, vs €149 on its own. The full WGS report plus the Deep Read panel, prepaid together.
- Everything in the full report
- Deep Read: 29-gene pharmacogenomic panel
- CYP2D6 star-allele resolution
- Per-gene callability, measured directly
Add when you are ready
Deep Read
The answers only your aligned reads hold. Where most consumer tests read a handful of drugs, Deep Read reads 29 pharmacogenes to CPIC star-allele resolution — and turns them into a one-page hand-off to take to your prescriber. It costs a little more than the full report because it reads tens of gigabytes of aligned data with lab-grade star-allele calling, a specialist analysis a standard VCF cannot do. Most people save by taking it in the bundle.
- 29-gene panel: CYP2D6, CYP2C19, TPMT, DPYD, SLCO1B1 and more
- CYP2D6 star-allele resolution, the pharmacogene a VCF cannot reliably call
- A one-page medication hand-off to take to your prescriber
- Per-gene callability, measured directly
- A record of what we examined, gene by gene
- Reads processed, then deleted immediately
Why does this panel need aligned reads?
CYP2D6 is the clearest example. It governs how the body metabolises dozens of common drugs, from antidepressants to codeine, and its gene structure (duplications, deletions, pseudogene interference) means a standard VCF cannot call it reliably. The same aligned reads also drive the wider 29-gene panel of pharmacogenes that are structurally complex or need full read evidence to call confidently. Deep Read measures, gene by gene, the fraction of bases we could examine at read depth of 10× or more, turning "not found" into "examined, and not found".
Offered from your dashboard once your report is ready, so there is no large upload up front. Prepay it with the bundle to save €39.
Start with the full reportRe-analysis
Your genome doesn't change — what we know about it does. Keep any report live for €29/yr and we re-read your file as the science moves; your dashboard flags when new data is ready. Without it, your report stays the snapshot you bought.
- Silent re-matching of your variant file
- "What changed" updates as the science moves
- Only your normalised variants are kept
- You keep every report you have ever had. The subscription only adds new updates
- Cancel any time
No hidden fees. No data resale (that is how the "free" services pay). One transparent price for a careful, attributed re-analysis you own.
What each file type unlocks
The same coverage table we show you before you pay. A number is how many items we examine in a module; a tick means included; a dash means that file type cannot deliver it.
| What you get | Chip | WGS | WGS + Deep Read |
|---|---|---|---|
| Clinical findings | 2 examined | 39 examined | 39 examined |
| Carrier status | Not available | 55 examined | 55 examined |
| Pharmacogenomics | 8 examined*, see note | 8 examined | 8 examined |
| Traits | 23 examined | 23 examined | 23 examined |
| Frontier | 38 examined | 38 examined | 38 examined |
| The Fringe | 22 examined | 22 examined | 22 examined |
| Polygenic scores | 4 examined | 4 examined | 4 examined |
| Ancestry: maternal (mtDNA) | 11 examined | 11 examined | 11 examined |
| Ancestry: paternal (Y-DNA) | 14 examined | 14 examined | 14 examined |
| APOE risk allele (e4) | Included | Included | Included |
| Lp(a) level | Included | Included | Included |
| Hemochromatosis (HFE) variants | Included | Included | Included |
| ABO blood type | Included | Included | Included |
| APOL1 risk variants | Included | Included | Included |
| Deep Read: 29-gene PGx panel + callability | Not available | Not available | 29 examined |
* Array-dependent: only the genes whose defining SNPs your chip typed.
A number is how many items we examine; means included; a dash () means that file type can't deliver it. Counts are the most a file of that type can unlock, not a promise for every file.
These are curated, reviewed panels, not a comprehensive genome-wide screen, and the absence of a finding is not a clean result. A chip only reports the specific variants it typed, so its counts are an upper bound; full clinical findings and carrier status need whole-genome data (WGS). Counts are version-stamped (2026-07-16) from the analysis registries. Polygenic scores are calibrated to broad ancestry groups and report your percentile against a reference population, not a personal probability of disease. Drop your file to see what your data unlocks.
Where Aimosti sits
| Service | Price | Updates | Input | Note |
|---|---|---|---|---|
| Genetic Genie | Free | Frozen | chip / VCF | Ad-supported, stale curation |
| Promethease | ~€23 | Frozen | chip / VCF | One-time SNPedia report, dense |
| SelfDecode | ~€92 / yr | Rented | chip (imputed) | Access stops when you stop paying |
| Aimosti | €119 once | Current & yours | whole-genome / chip | WGS-native (chip welcome), attributed, EU-sovereign |
Every other option hands you a one-time report frozen at the day you run it, or rents you ongoing access. Aimosti re-reads your file as the science moves, and the report stays yours. We are not the cheap option; we are the careful one: WGS-native depth, fresh pinned curation, EU data sovereignty, and a report built to be read. And we never impute: where others guess the genotypes your chip missed, a no-call stays a no-call, so a result is something you can trust.
One report. Yours to keep.
Read in Finland, attributed to the source, never sold.
See what your file unlocks